Therapeutic substituted hydantoins, and related compounds

Details for Australian Patent Application No. 2009244539 (hide)

Owner Allergan, Inc.

Inventors Old, David W.

Agent Davies Collison Cave

Pub. Number AU-A-2009244539

PCT Pub. Number WO2009/137343

Priority 61/051,795 09.05.08 US

Filing date 1 May 2009

Wipo publication date 12 November 2009

International Classifications

C07D 233/78 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4166 (2006.01)

A61K 31/4172 (2006.01)

A61K 31/4178 (2006.01)

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 27/00 (2006.01) Drugs for disorders of the senses

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

9 December 2010 PCT application entered the National Phase

  PCT publication WO2009/137343 Priority application(s): WO2009/137343

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009244541-Therapeutic compounds

2009244538-Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido [ 3, 2, 1-I J ] quinoline compounds